Weitzel, Jeffrey N. http://orcid.org/0000-0001-6714-092X
Kidd, John
Bernhisel, Ryan
Shehayeb, Susan
Frankel, Paul
Blazer, Kathleen R.
Turco, Diana
Nehoray, Bita
McGreevy, Kim
Svirsky, Kira
Brown, Krystal
Gardiner, Anna
Daly, Mary
Hughes, Elisha
Cummings, Shelly
Saam, Jennifer
Slavin, Thomas P.
Funding for this research was provided by:
Breast Cancer Research Foundation
Dr. Norman & Melinda Payson Professorship
National Cancer Institute (R01CA242218, K08CA234394)
National Institutes of Health (P30CA033572)
Conquer Cancer Foundation (Research Professorship in Breast Cancer Diaparities)
Article History
Received: 3 November 2020
Accepted: 16 March 2021
First Online: 7 April 2021
Declarations
:
: Authors JK, RB, DT, KM, KS, KB, AG, EH, SC, JS and TS were employees of Myriad Genetics at the time of manuscript preparation and had stock options. JNW received speaker fees from AstraZeneca. No other authors have any conflict of interest to disclose.
: All individuals provided consent for clinical testing, and testing data were de-identified for analysis.
: All individuals provided consent for clinical testing, and testing data were de-identified for analysis.
: All authors have provided consent for the manuscript to be submitted for review and publication in the journal <i>Breast Cancer Research and Treatment</i>.